Agios Pharmaceuticals Inc (STU:8AP)
€ 45.8 0.8 (1.78%) Market Cap: 2.49 Bil Enterprise Value: 1.59 Bil PE Ratio: 4.05 PB Ratio: 1.61 GF Score: 28/100

Agios Pharmaceuticals Inc Investor Event to Review Data Presented at ASH Transcript

Dec 10, 2019 / 01:00AM GMT
Release Date Price: €38.06 (-4.28%)
Unidentified Company Representative

All right, great. We're going to get started. So good evening and welcome, everyone. Thank you for joining us at the tail end of what's been an exciting and kind of long conference for some of us.

Before we begin, I do want to let you know that Jackie wishes she could be here. But as some of you know, several weeks ago, she had a hip replacement surgery. We felt like walking around the conference in Orlando, probably wasn't a good path to recovery. So I think I did 3 miles today before 10 a.m. So anyway, she's looking forward to seeing you all in San Francisco next month.

So here's our forward-looking statements disclaimer. As you know, those are subject to risks and uncertainties, which are outlined in our SEC filings. I'll start by giving you a bit of an overview. I'll provide some opening remarks on where we are on some of our corporate milestones, and then I'll turn it over to Chris to walk through some of the IDH data that we presented at the conference, and then we're lucky to have Dr. Eduard van Beers here to talk to us about the DRIVE PK data that we

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot